India Vaue Fund Advisors (IVFA) has bought a 10% stake in Syngene International, the research unit of Indian bio-pharmaceuticals firm Biocon, for INR3.8 billion ($62 million).
South Asia | 19 Sep 2014 |
Xiaomi Ventures, a corporate VC unit of Chinese mobile phone maker Xiaomi, has paid $25 million for a 20% stake in iHealth, an offshore unit of healthcare electronics maker Andon Health.
Greater China | 19 Sep 2014 |
Temasek Holdings has received approval from the Competition Commission of India (CCI) to acquire a stake in Intas Pharmaceuticals from ChrysCapital Partners.
Healthcare | 17 Sep 2014 |
Few VC firms are keen to invest in China's early-stage drug discovery space because the development cycle is long and risky. Taking a new drug from clinical testing to commercialization often takes 7-10 years and the success rate in China is less than...
Healthcare | 11 Sep 2014 |
Zhongyuan Union Stem Cell Bio-engineering, a Chinese stem cell storage service operator, has partnered with China Yinhong Capital to launch an industry M&A fund with a target of RMB5 billion ($813 million).
Greater China | 03 Sep 2014 |
OrbiMed has committed $15 million in Series B funding to GC-Rise Pharmaceutical, a Chinese healthcare services provider.
Healthcare | 03 Sep 2014 |
Tencent Holdings has invested $70 million into dxy.com, a Chinese networking and information-sharing site for healthcare professionals
Venture | 03 Sep 2014 |
Qiming Venture Partners has led a $30 million Series A round of funding for Zai Lab, a Shanghai-based biotech drug developer, with participation from KPCB, Sequoia Capital and TF Capital.
Greater China | 01 Sep 2014 |
Hony Capital has made its second partial exit from CSPC Pharmaceutical Group in three months, selling an 11% stake in the Hong Kong-listed Chinese generic drugs maker for HK$4.01 billion ($528 million).
Exits | 29 Aug 2014 |
CITIC Private Equity will exit a 10.26% stake in Beijing Jialin Pharmaceutical after Luye Pharma Group, a Chinese drug maker, agreed to buy a majority stake in its industry peer.
Greater China | 28 Aug 2014 |
Advent Private Capital has created the fourth-largest radiology group in Australia by bringing together two independent diagnostics businesses, Lake Imaging and South Coast Radiology.
Australasia | 27 Aug 2014 |
Sequoia Capital has acquired a 7% stake in Jiangsu Yuyue Medical Equipment & Supply, a Chinese medical equipment manufacturer, for RMB856 million ($139 million).
Greater China | 25 Aug 2014 |
CITIC Private Equity has abandoned plans for a takeover of Singapore-listed Biosensors International, although it will remain an active investor in the medical device manufacturer.
Buyouts | 20 Aug 2014 |
Walden Riverwood Ventures has led an $8 million Series A round of funding for Atonarp, a Japanese developer of chemical sensors.
Early stage | 14 Aug 2014 |
Sabre Partners as led an $8 million Series B round of funding for Vyome Biosciences, an Indian bio-pharmaceutical company that specializes in dermatology.
Venture | 14 Aug 2014 |
Updating your subscription status
The AVCJ Forum will explore real asset investment opportunities and challenges and will offer an in-depth look at the ways in which the private equity industry is supporting and funding the region's remarkable development story.
28 August 2014, Four Seasons Hotel, Singapore
Join the debate and hear LPs discuss return expectations, the changing PE landscape and the key elements they look for when selecting a GP.
Also, hear industry experts from across the globe share predictions on the markets and sectors that will deliver winning returns and advice on how to access and develop lasting relationships with the top performing GPs.
For foreign fund managers who plan to add Korea to their next fundraising initiative, and Korean LPs that are searching for overseas investments, the AVCJ Korea Forum is a must attend event.
11 September 2014, The Westin Chosun Hotel, Seoul